Lung Cancer
OCEANiC
A study on the effect of Osimertinib, with or without Adjuvant Chemotherapy, Guided by Tumour Next Generation Sequencing (NGS) Co-mutation Status and circulating tumour DNA (ctDNA) Detection on disease-free survival in Patients with Stage IIA-IIIA epidermal growth factor receptor (EGFR)-Mutant Non-Small Cell Lung Cancer Following Complete Surgical Resection
Trial overview
Medical Oncology
Lung cancer
II
Number: ACTRN12623000552684
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385294
North Shore
North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia
(02) 8037 4100 admin.northshore@genesiscare.comMedical Oncologist
Prof. Nick Pavlakis
BSc MBBS MMed PhD FRACP
Frenchs Forest (Oncology) +1
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.